-
1
-
2
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2′)-Orn-NH2] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2′)-Arg-NH2]
Veröffentlicht in Journal of medicinal chemistry
VolltextArtikel -
3
-
4
-
5
-
6
The NAL-NL2 Prescription Procedure
Veröffentlicht in Audiology research (Pavia, Italy)
VolltextArtikel -
7
-
8
-
9
-
10
-
11
Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study)
Veröffentlicht in Journal of clinical oncology
VolltextArtikel -
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Laser ignition of solid propellants using energetic nAl-PVDF optical sensitizers
Veröffentlicht in Combustion and flame
VolltextArtikel -
20